Zhang Jianlu, Li Weiqing, Li Ying, Amin Buhe, Zhang Nengwei, Sun Zhipeng, Zhu Bin
Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Department of Thoracic Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Wideochir Inne Tech Maloinwazyjne. 2022 Jun;17(2):344-351. doi: 10.5114/wiitm.2022.113567. Epub 2022 Feb 18.
To date, long-term safety including functional outcomes of transanal natural orifice specimen extraction surgery (NOSES) for colorectal cancer resection has not been confirmed.
To explore the short- and long-term outcomes as well as anal function of transanal NOSES versus conventional laparoscopic surgery for sigmoid colon or rectal cancer resection.
A retrospective review of data from a prospectively maintained database was performed to analyze the data of 69 patients who underwent transanal NOSES for sigmoid colon or rectal cancer resections and another 69 matched patients who underwent conventional laparoscopic (CL) surgery. Anal function of patients was evaluated using the Wexner fecal incontinence scale postoperatively.
Transanal NOSES resulted in faster recovery of intestinal function, shorter postoperative length of stay, less incisional pain, fewer postoperative complications and shorter scars than CL surgery (p < 0.05). The two groups had similar overall survival (p = 0.863) and disease-free survival (p = 0.961). Wexner scores of the NOSES group at 1, 3 and 6 months after surgery were higher than in the CL group (p < 0.05), and there was no difference between the two groups at 12, 18 and 24 months after surgery.
Transanal NOSES achieves similar survival outcomes to CL surgery. Transanal NOSES has the advantages of faster recovery, shorter postoperative hospital stay, less incisional pain, shorter scars, etc. However, transanal NOSES can indeed impair anal function, needing more attention.
迄今为止,经肛门自然腔道标本取出手术(NOSES)用于结直肠癌切除的长期安全性,包括功能结局,尚未得到证实。
探讨经肛门NOSES与传统腹腔镜手术治疗乙状结肠癌或直肠癌切除的短期和长期结局以及肛门功能。
对前瞻性维护数据库中的数据进行回顾性分析,分析69例行乙状结肠癌或直肠癌切除经肛门NOSES的患者以及另外69例匹配的行传统腹腔镜(CL)手术患者的数据。术后使用韦克斯纳大便失禁量表评估患者的肛门功能。
与CL手术相比,经肛门NOSES导致肠道功能恢复更快、术后住院时间更短、切口疼痛更少、术后并发症更少且瘢痕更短(p<0.05)。两组的总生存期(p=0.863)和无病生存期(p=0.961)相似。NOSES组术后1、3和6个月的韦克斯纳评分高于CL组(p<0.05),术后12、18和24个月两组之间无差异。
经肛门NOSES与CL手术的生存结局相似。经肛门NOSES具有恢复更快、术后住院时间更短、切口疼痛更少、瘢痕更短等优点。然而,经肛门NOSES确实会损害肛门功能,需要更多关注。